UK appraises PET and CT in breast cancer recurrence
This article was originally published in Clinica
Executive Summary
The UK NHS' health technology assessment (HTA) programme has launched a study into the clinical and cost-effectiveness of positron emission tomography (PET) and PET/computed tomography (CT) in breast cancer recurrence.